Skip to main content
Premium Trial:

Request an Annual Quote

Cellexus Lands Canadian Distributor

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – UK-based bioreactor maker Cellexus said today that it has signed up Vancouver-based life and analytical sciences company Discovery Scientific to distribute its products in Canada.

Cellexus supplies the CellMaker line of single-use disposable bioreactors for use in cell culture and fermentation bioprocesses.

Cellexus of Huntington, UK, said that the distribution agreement is part of an expansion strategy to drive up sales in key regions.

“Selling into Canada presents unique challenges so it makes good business sense for use to work with Discovery Scientific, with the local knowledge and expertise as well as an established client base, to drive sales in this geography,” Cellexus’ Chief Operating Office Paul Stubbings added.

Filed under

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.